Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. X:X | DOI: 10.5507/bp.2024.039

Uterine artery embolisation in symptomatic patients with placenta accreta spectrum disorders

David Brustman1, Jan Raupach1, 2, Vendelin Chovanec1, Pavel Ryska1, 2
1 Department of Radiology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
2 Department of Radiology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic

Objectives: Postpartum haemorrhage is the most common cause of mortality among women after childbirth. Therefore, this work aims to highlight the possibility of endovascular treatment of postpartum haemorrhage due to remnants in patients with placenta accreta spectrum disorders (PAS disorders) using selective UAE after failure of the standard management. This procedure is a relatively safe and technically nondemanding, with a low risk of recurrent vaginal bleeding.

Materials and Methods: This article presents an evaluation of the results of eight patients (age between 19-39 years) who underwent selective transarterial embolisation of uterine arteries from January 2022 to August 2023 at the angio-interventional department of our university hospital center. Based on a multidisciplinary consensus of sonographically detected residues of placenta accreta with typical hypervascularisation, unilateral/bilateral embolisation of the uterine artery was performed with a microcatheter using polyvinyl alcohol embolisation particles, possibly in combination with gelatine foam.

Results: There were no periprocedural complications during embolisation, nor were there episodes of repeated bleeding or other postprocedural complications during the follow-up. Two patients underwent surgical revision of the uterine cavity with extirpation of devascularised residual tissue.

Conclusions: Thus far, this procedure has proven to be a safe and relatively technically nondemanding method supplementing the management of symptomatic patients with PAS disorders with a low risk of rebleeding.

Keywords: uterine artery embolisation, endovascular treatment, postpartum haemorrhage, retained placenta, placenta accrete

Received: September 18, 2024; Revised: November 18, 2024; Accepted: December 3, 2024; Prepublished online: December 16, 2024 

Download citation

References

  1. World Health Organisation. Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division 2023. Available from: https://www.who.int/publications/i/item/9789240068759
  2. Biele C, Radtke L, Kaufner L, Osei A, Möller P, Baier K, Heine G. Does the use of chitosan-covered gauze for postpartum hemorrhage reduce the need for surgical therapy including hysterectomy? A databased historical cohort study. Journal of Perinatal Medicine 2022;50(8):1078-86. Go to original source... Go to PubMed...
  3. Perlman NC, Carusi DA. Retained placenta after vaginal delivery: risk factors and management. Int J Womens Health 2019;11:527-34. doi: 10.2147/IJWH.S218933 Go to original source... Go to PubMed...
  4. Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One 2012;7(12):e52893. Go to original source... Go to PubMed...
  5. Jauniaux E, Collins SL, Jurkovic D, Burton GJ. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol 2016;215(6):712-21. doi: 10.1016/j.ajog.2016.07.044 Go to original source... Go to PubMed...
  6. Akol AD, Weeks AD. Retained placenta: will medical treatment ever be possible? Acta Obstet Gynecol Scand 2016;95(5):501-4. doi: 10.1111/aogs.12848 Go to original source... Go to PubMed...
  7. Lin F, Chen Z, Tao H, Ren X, Ma P, Lash GE, Shuai H, Li P. Sonographic Findings of Vascular Signals for Retained Products of Conception in Women Following First-Trimester Termination of Pregnancy. J Obstet Gynaecol Can 2024;46(3):102266. doi: 10.1016/j.jogc.2023.102266 Go to original source... Go to PubMed...
  8. Goh WA, Zalud I. Placenta accreta: diagnosis, management, and the molecular biology of the morbidly adherent placenta. J Matern Fetal Neonatal Med 2016;29(11):1795-800. doi: 10.3109/14767058.2015.1064103 Go to original source... Go to PubMed...
  9. Lee MHM. Surgical management of retained placental tissue with the hysteroscopic morcellation device. Gynecol Minim Invasive Ther 2019;8(1):33-5. doi: 10.4103/GMIT.GMIT_66_18 Go to original source... Go to PubMed...
  10. Brown BJ, Heaston DK, Poulson AM, Gabert HA, Mineau DE, Miller FJ Jr. Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolization. Obstet Gynecol 1979;54(3):361-5.
  11. Mitty HA, Sterling KM, Alvarez M, Gendler R. Obstetric hemorrhage: prophylactic and emergency arterial catheterization and embolotherapy. Radiology 1993;188(1):183-7. Go to original source... Go to PubMed...
  12. Farquhar CM, Li Z, Lensen S, McLintock C. Incidence, risk factors, and perinatal outcomes for placenta accreta in Australia and New Zealand: a case-control study. BMJ Open 2017;7(10):e017713 Go to original source... Go to PubMed...
  13. Betran AP, Ye J, Moller AB, Souza JP, Zhang J. Trends and projections of caesarean section rates: global and regional estimates. BMJ Global Health 2021;6(6):e005671 Go to original source... Go to PubMed...
  14. Spies JB. What do we know about uterine-ovarian anastomoses and uterine artery embolization? J Vasc Interv Radiol 2012;23(5):602-3. doi: 10.1016/j.jvir.2012.02.016 Go to original source... Go to PubMed...
  15. Lanciego C, Diaz-Plaza I, Ciampi JJ, Barbosa ML, Rojas E, Olivares J. Utero-ovarian anastomoses and their influence on uterine fibroid embolization. J Vasc Interv Radiol 2012;23(5):595-601. Go to original source... Go to PubMed...
  16. Korff RA, Warhit M, Jagust MB, Golowa YS, Cynamon JB, Rassouli M. The role of non-contrast cone beam CT in identifying incomplete treatment during uterine artery embolization. J Vasc Interv Radiol 2019;30(5):679-86. Go to original source... Go to PubMed...
  17. Alabdulghani F, O'Brien A, Brophy D, Barrett R. Application of cone-beam computed tomography angiography in a uterine fibroid embolization procedure: A case report. Radiol Case Rep 2017;13(1):130-4. doi: 10.1016/j.radcr.2017.09.027 Go to original source... Go to PubMed...
  18. Takeda A, Koike W, Katayama T, Kawanishi T. Uterine artery chemoembolization followed by hysteroscopic resection for management of retained placenta accreta with marked vascularity after evacuation of first-trimester miscarriage in angular pregnancy: A case report. Case Rep Womens Health 2021;32:e00360. doi: 10.1016/j.crwh.2021.e00360 Go to original source... Go to PubMed...
  19. Toor SS, Jaberi A, Macdonald DB, McInnes MD, Schweitzer ME, Rasuli P. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR Am J Roentgenol 2012;199(5):1153-63. doi: 10.2214/AJR.11.8362 Go to original source... Go to PubMed...
  20. Soro MP, Denys A, de Rham M, Baud D, Goutier J. Short & long-term adverse outcomes after arterial embolisation for the treatment of postpartum hemorrhage: a systematic review. Eur Radiol 2017;27(2):749-62. Go to original source... Go to PubMed...
  21. Bazeries P, Paisant-Thouveny F, Yahya S, Faure N, Dufresne A, Benayoun L, Lapaire O, Mirza K. Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment. Cardiovasc Intervent Radiol 2017;40(4):520-9. doi: 10.1007/s00270-016-1543-7 Go to original source... Go to PubMed...
  22. Zhang XQ, Chen XT, Zhang YT, Mai CX. The emergent pelvic artery embolization in the management of postpartum hemorrhage: A systematic review and meta-analysis. Obstet Gynecol Surv 2021;76(4):234-44. doi: 10.1097/OGX.0000000000000887 Go to original source... Go to PubMed...
  23. Nocum DJ, Robinson J, Halaki M, Shah S, Moore M, Peppé N, Howard P, Robinson J. Identifying predictors of patient radiation dose during uterine artery embolisation. J Med Radiat Sci 2021;68(2):131-8. doi: 10.1002/jmrs.450 Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.